By DAVE SMITH The International Business Times
Canadian researchers from the University of Western Ontario in London claim they have developed a promising HIV vaccine, which has received the green light by U.S. FDA officials to begin testing on humans.
Canadian researchers from the University of Western Ontario in London claim they have developed a promising HIV vaccine, which has received the green light by U.S. FDA officials to begin testing on humans.
"We started the basic science research two decades ago,"said Dr. Chil-Yong Kang, the lead researcher for the project. "The vaccine development, we started 10 years ago. This is incredible for us to get to this stage of development."
This HIV vaccine, called "SAV001," was developed with the support from Sumagen Canada, a biotech company designed to drive clinical development of Kang's work. It is the only HIV vaccine currently being developed in Canada.
The first of three clinical trials began in January, which used 40 volunteers that already had the HIV virus. The experimental medicine was awarded funds on Jan. 12 to support clinical trials of the vaccine

